[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610982":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":32,"locations":41,"responsibleParty":89,"collaborators":93,"id":96,"slug":97,"hasResults":98,"nctId":99,"briefTitle":100,"officialTitle":101,"acronym":102,"eligibilityCriteria":103,"healthyVolunteers":104,"sex":105,"minAge":10,"maxAge":10,"enrollmentInfo":106,"targetDuration":10,"studyType":109,"phases":10,"briefSummary":110,"conditions":111,"keywords":114,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":125,"locationsCount":126},{"fullName":5,"class":6},"Gødstrup Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Panel members",null,"6 patients with spouses\u002Fpartners and 3 single patients. In total 15 subjects.",[13],"Other: Phase 1: Establishment of a patient-partner panel",{"label":15,"type":10,"description":16,"interventionNames":17},"Pilot population","In total 90 subjects (patients with or without partners)",[18],"Other: Phase 2: Feasibility testing of FCR questions, mode of administration and timing for investigating Fear of Cancer Recurrence",[20,24],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Phase 1: Establishment of a patient-partner panel","Phase 1: Establishment of a patient-partner panel who in collaboration with researchers define Fear of Cancer Recurrence questions, mode of administration and timing for investigating Fear of Cancer Recurrence in phase 2 (pilot testing in a feasibility study).",[9],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"Phase 2: Feasibility testing of FCR questions, mode of administration and timing for investigating Fear of Cancer Recurrence","As the intervention for phase 2 is a product of the collaboration and discussions between panel members and researchers during phase 1, the intervention can not be described more detailed.",[15],[29],{"name":30,"affiliation":5,"role":31},"Brigitta R Villumsen, PhD","STUDY_CHAIR",[33,37],{"name":30,"role":34,"phone":35,"phoneExt":10,"email":36},"CONTACT","+45 20487820","brigvill@rm.dk",{"name":38,"role":34,"phone":39,"phoneExt":10,"email":40},"Anne H Nielsen, PhD","+45 2015 8924","annsve@rm.dk",[42,60,74],{"facility":43,"status":44,"city":45,"state":10,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Aalborg University Hospital","RECRUITING","Aalborg","9000","Denmark","DK",{"type":50,"coordinates":51},"Point",[52,53],9.9187,57.048,{"lat":53,"lon":52},[56],{"name":57,"role":34,"phone":58,"phoneExt":10,"email":59},"Tommy K Nielsen, PhD","+45 97656359","t.kjaergaard@rn.dk",{"facility":61,"status":44,"city":62,"state":10,"zip":63,"country":47,"countryCode":48,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Aarhus University Hospital","Aarhus","8200",{"type":50,"coordinates":65},[66,67],10.21076,56.15674,{"lat":67,"lon":66},[70],{"name":71,"role":34,"phone":72,"phoneExt":10,"email":73},"Anna K Keller, PhD","+ 45 2029 8015","anna.keller@clin.au.dk",{"facility":5,"status":44,"city":75,"state":10,"zip":76,"country":47,"countryCode":48,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Herning","7400",{"type":50,"coordinates":78},[79,80],8.97662,56.13615,{"lat":80,"lon":79},[83,85,86],{"name":84,"role":34,"phone":10,"phoneExt":10,"email":10},"Mette S Olesen, MSN",{"name":30,"role":34,"phone":35,"phoneExt":10,"email":10},{"name":87,"role":88,"phone":10,"phoneExt":10,"email":10},"Charlotte G Jensen, PhD","PRINCIPAL_INVESTIGATOR",{"type":90,"investigatorFullName":91,"investigatorTitle":92,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Brigitta Rasmussen Villumsen","Principal Investigator",[94,95],{"name":61,"class":6},{"name":43,"class":6},"100610982","patient-partnered-research-in-investigating-fear-of-cancer-recurrence-in-kidney-cancer-100610982",false,"NCT07234656","Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer","Patient-partnered Research: a Key to Investigating Fear of Cancer Recurrence in Patients With Surgically Treated Kidney Cancer (PP-RECURK)","PP-RECURK","Inclusion Criteria:\n\nPhase 1:\n\n* Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner\u002Fspouse\n* Partner\u002Fspouse to patients who fullfil the inclusion criteria\n* Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor)\n* Time since surgery: 0-120 months\n* Danish speaking patients and partners\u002Fspouses. Must be able to speak, write and read Danish\n* Patients\u002Fpartners\u002Fspouses able to and willing to attend online project meetings or in person at Gødstrup Hospital.\n\nPhase 2:\n\n* Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner\u002Fspouse\n* Partner\u002Fspouse to patients who fullfill the inclusion criteria\n* Patients who have undergone surgery due to localized RCC (T1-T2-T3 tumor)\n* Danish speaking patients and partners\u002Fspouses. Must be able to speak, write and read Danish\n* Able to receive digital communication from the hospital\n* Informed consent must be signed before answering Fear of Cancer Recurrence questions\n\nExclusion Criteria:\n\nBoth phases, both patients and partners\u002Fspouses:\n\n* Diagnosed with cognitive impairment\n* Untreated psychiatric disorders due to non-compliance\n\nPhase 2:\n\n• Patients and partners\u002Fspouses who were panelists in phase 1",true,"ALL",{"count":107,"type":108},105,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to gather real-world information about Fear of Cancer Recurrence (FCR) following surgery in patients with renal cell carcinoma (RCC) and their partners\u002Fspouses by 1) establishing a panel consisting of patients with or without partners\u002Fspouses to facilitate patient-partnered research. Furthermore, 2) Through discussions among panel members and researchers identification of the most pertinent topics related to FCR, as well as the optimal timing and methods for collecting that information in the follow-up care after surgery. Finally, to conduct a feasibility and pilot study to investigate the feasibility of the recommendations developed in 1) + 2) and assess FCR in patients with RCC following surgery and their partners\u002Fspouses.\n\nIn phase 1 participants (panel members) will be asked to collaborate with researchers in the development of recommendations for FCR questions, mode of administration and timing in the follow-up care after surgically treated kidney cancer.\n\nIn phase 2 participants (patients and partners) in follow-up care after surgically treated kidney cancer are asked to answer questions about FCR at specific timepoints defined by panel members and researchers in phase 1.",[112,113],"Fear of Cancer Recurrence","Renal Cell Carcinoma (Kidney Cancer)",[112,115,116],"Patient involvement in research","Kidney cancer","2026-03-31",{"date":119,"type":120},"2026-04-01","ACTUAL",{"date":122,"type":120},"2025-09-30",{"date":124,"type":108},"2028-02",{"name":91,"class":6},3]